Treating patients with comorbidities

Drug Treatment: What Works?

Volumn , Issue , 2004, Pages 123-141

  Seivewright, Nicholas ^a   Iqbal, Muhammad Z ^b   Bourne, Helen ^c  

^a SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^b Leicester University ^*  (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744460734     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203646595     Document Type: Chapter

References (86)

1. Advisory Council on the Misuse of Drugs (1988) AIDS and Drug Misuse, Part 1, Department of Health, London: Her Majesty's Stationery Office.
2. Advisory Council on the Misuse of Drugs (1989) AIDS and Drug Misuse, Part 2, Department of Health, London: Her Majesty's Stationery Office.
3. Alter, M. J. (1999) 'Hepatitis C Virus Infection in the United States', Journal of Hepatology 31 (Suppl. 1): 88-91.
4. Alter, M. J. and Moyer, L. A. (1998) 'The Importance of Preventing Hepatitis C Virus Infection among Injection Drug Users in the United States', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 (Suppl. 1): 6-10.
5. Baker, A., Heather, N., Wodak, A., Dixon, J. and Holt, P. (1993) 'Evaluation of a Cognitive Behavioural Intervention for HIV Prevention among Injecting Drug Users', AIDS 7:247-56.
6. Bartels, S. J., Teague, G. B., Drake, R. E., Clarke, R. E., Bush, P. W. and Noordsy, D. L. (1993) 'Service Utilisation and Costs Associated with Substance Use Disorder among Severely Mentally Ill Patients', Journal of Nervous and Mental Disease 181: 227-32.
7. Bebbington, P. E. (1995) 'The Content and Context of Compliance', International Clinical Psychopharmacology 9 (supplement 5): 41-50.
8. Bertschy, G. (1995) 'Methadone Maintenance Treatment: An Update', European Archives of Psychiatry and Clinical Neuroscience 245: 114-24.
9. Boutros, N. N. and Bowers, M. B. Jnr (1996) 'Chronic Substance-induced Psychotic Disorders:State of the Literature', Journal of Neuropsychiatry and Clinical Neuroscience 8: 262-9.
10. Brizer, D. A., Hartman, N., Sweeney, J. and Millman, R. B. (1985) 'Effect of Methadone Plus Neuroleptics on Treatment-resistant Chronic Paranoid Schizophrenia', American Journal of Psychiatry 142: 1,106-7.
11. Buckley, P. F. (1998) 'Substance Abuse in Schizophrenia: A Review', Journal of Clinical Psychiatry 59 (supplement 3): 26-30.
12. Buning, E. C., van Brussel, G. H. A., van Santen, M. D. and van Santen, G. (1990) 'The "Methadone by Bus" Project in Amsterdam', British Journal of Addiction 85: 1,247-50.
13. Carey, M. P., Carey, K. B., Weinhardt, L. S. and Gordon, C. M. (1997) 'Behavioural Risk for HIV Infection among Adults with a Severe and Persistent Mental Illness: Patterns and Psychological Antecedents', Community Mental Health Journal 33: 133-42.
14. Carnwath, T. and Hardman, J. (1998) 'Randomised Double-blind Comparison of Lofexidine and Clonidine in the Outpatient Treatment of Opiate Withdrawal', Drug & Alcohol Dependence 50: 251-4.
15. Checkley, G. E., Thompson, S. C., Crofts, N., Mijch, A. M. and Judd, F. K. (1996) 'HIV in the Mentally Ill', Australian and New Zealand Journal of Psychiatry 30: 184-94.
16. Connell, P. H. (1958) Amphetamine Psychosis, Institute of Psychiatry Maudsley Monograph No. 5, London: Oxford University Press.
17. Crome, I. B. (1999) 'Substance Misuse and Psychiatric Comorbidity: Towards Improved Service Provision', Drugs, Education, Prevention and Policy 6: 151-74.
18. Cuffell, B. J., Shumway, M., Chouljian, T. L. and MacDonald, T. (1994) 'A Longitudinal Study of Substance Use and Community Violence in Schizophrenia', Journal of Nervous and Mental Disease 182: 704-8.
19. Cunningham Owens, D. G. and Johnstone, E. C. (2000) 'Treatment and Management of Schizophrenia', in M. G. Gelder, J. J. Lopez-Ibor Jnr and N. C. Andreasen (eds) New Oxford Textbook of Psychiatry, Oxford: Oxford University Press.
20. Darke, S., Hall, W. and Swift, W. (1994) 'Prevalence, Symptoms and Correlates of Antisocial Personality Disorder among Methadone Maintenance Clients', Drug and Alcohol Dependence 34: 253-7.
21. Davoli, M., Perucci, C. A., Forastiere, F., Doyle, P., Rapiti, E., Zaccarelli, M. and Abeni, D. D. (1993) 'Risk Factors for Overdose Mortality: A Case Control Study within a Cohort of Intravenous Drug Users', International Journal of Epidemiology 22: 273-7.
22. Dixon, L. (1999) 'Dual Diagnosis of Substance Abuse in Schizophrenia: Prevalence and Impact on Outcomes', Schizophrenia Research 35 (supplement): 93-100.
23. Drake, R. E. and Mueser, K. T. (2000) 'Psychosocial Approaches to Dual Diagnosis', Schizophrenia Bulletin 26: 105-18.
24. Drake, R. E. and Wallach, M. A. (1989) 'Substance Abuse among the Chronically Mentally Ill', Hospital and Community Psychiatry 40: 1,041-6.
25. Drake, R. E., Bartels, S. J., Teagues, G. B., Noordsy, D.L. and Clark, R. E. (1993) 'Treatment of Substance Abuse in Severely Mentally Ill Patients', Journal of Nervous and Mental Disease 181: 606-11.
26. Drake, R. E., McHugo, G. M., Clark, R. E., Teague, G. B., Ackerson, T., Xie, H. and Miles, K. M. (1998) 'A Clinical Trial of Assertive Community Treatment for Patients with Cooccurring Severe Mental Illness and Substance Use Disorder', American Journal of Orthopsychiatry 68: 201-15.
27. Farrell, M., Battersby, M. and Strang, J. (1990) 'Screening for Hepatitis B and Vaccination of Injecting Drug Users in the NHS Drug Treatment Services', British Journal of Addiction 85: 1,657-9.
28. Farren, C. K. (1997) 'The Use of Naltrexone, an Opiate Antagonist, in the Treatment of Opiate Addiction', Irish Journal of Psychological Medicine 14: 26-31.
29. Galanter, M., Egelko, S., Edwards, H. and Vergaray, M. (1994) 'A Treatment System for Combined Psychiatric and Addictive Illness', Addiction 89: 1,227-35.
30. Gill, K., Nolimal, D. and Crowley, T. J. (1992) 'Antisocial Personality Disorder, HIV Risk Behaviour and Retention in Methadone Maintenance Therapy', Drug and Alcohol Dependence 30: 247-52.
31. Gillett, P., Hallam, N. and Mok, J. (1996) 'Vertical Transmission of Hepatitis C Virus Infection', Scandinavian Journal of Infectious Diseases 28: 549-52.
32. Glazer, W. M. (1997) 'Olanzapine and the New Generation of Antipsychotic Agents: Patterns of Use', Journal of Clinical Psychiatry 58: 18-21.
33. Godley, S. H., Finsh, M., Dougan, L., McDonnell, M., McDermeit, M. and Carey, A. (2000) 'Case Management for Dually Diagnosed Individuals Involved in the Criminal Justice System', Journal of Substance Abuse Treatment 18: 137-48.
34. Goldsmith, R. J. (2000) 'Overview of Psychiatric Comorbidity: Practical and Theoretical Considerations', Addictive Disorders 22: 331-49.
35. Hall, W. (1998) 'Cannabis and Psychosis', Drug and Alcohol Review 17: 433-44.
36. Hall, W. and Farrell, M. (1997) 'Comorbidity of Mental Disorders with Substance Misuse', British Journal of Psychiatry 171: 4-5.
37. Hoffman, G. W. Jnr, Dirito, D., McGill, E. (1993) 'Three-month Follow-up of 28 Dual Diagnosis Inpatients', American Journal of Drug and Alcohol Abuse 19: 79-88.
38. Jerrell, J. M. and Ridgely, M. S. (1999) 'Impact of Robustness of Program Implementation on Outcomes of Clients in Dual Diagnosis Programs', Psychiatric Services 50: 109-12.
39. Johns, A. (2001) 'Psychiatric Effects of Cannabis', British Journal of Psychiatry 178: 116-22.
40. Johnson, S. (1997) 'Dual Diagnosis of Severe Mental Illness and Substance Misuse: A Case for Specialist Services?', British Journal of Psychiatry 171: 205-8.
41. Jowett, S. L., Agarwal, K., Smith, B. C., Craig, W., Hewett, M., Bassendine, D. R., Gilvary, E., Burt, A. D., Bassendine, M. F. (2001) 'Managing Chronic Hepatitis C Acquired through Intravenous Drug Use', Quarterly Journal of Medicine 94: 153-8.
42. Khantzian, E. J. (1997) 'The Self-medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications', Harvard Review of Psychiatry 4: 231-44.
43. Klingemann, H. K. H. (1996) 'Drug Treatment in Switzerland: Harm Reduction, Decentralisation and Community Response', Addiction 91: 723-36.
44. Kokkevi, A. and Stefanis, C. (1995) 'Drug Abuse and Psychiatric Comorbidity', Comprehensive Psychiatry 36: 329-37.
45. Laudet, A. B., Magura, S., Vogel, H. S. and Knight, E. (2000) 'Recovery Challenges among Dually Diagnosed Individuals', Journal of Substance Abuse Treatment 18: 321-9.
46. Lehman, A. F., Myers, C. P., Thompson, J. W. and Corty, E. (1993) 'Implications of Mental and Substance Use Disorders: A Comparison of Single and Dual Diagnosis Patients', Journal of Nervous and Mental Disease 181: 365-70.
47. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. A. Jnr, Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I., Segal, D. (1998) 'Buprenorphine Maintenance Treatment of Opiate Dependence: A Multicenter, Randomized Clinical Trial', Addiction 93: 472-86.
48. McCrone, P., Menezes, P. R., Johnson, S., Scott, H., Thornicroft, G., Marshall, J., Bebbington, P. and Kuipers, E. (2000) 'Service Use and Costs of People with Dual Diagnosis in South London', Acta Psychiatrica Scandinavica 101: 464-72.
49. McDowell, D. M., Levin, F. R., Seracini, A. M., Nunes, E. V. (2000) 'Venlafaxine Treatment of Cocaine Abusers with Depressive Disorders', American Journal of Drug and Alcohol Abuse 26: 25-31.
50. Mant, A. and Walsh, R. A. (1997) 'Reducing Benzodiazepine Use', Drug and Alcohol Review 16: 77-84.
51. Marsch, L. A. (1998) 'The Efficacy of Methadone Maintenance Interventions in Reducing Illicit Opiate Use, HIV Risk Behaviour and Criminality: A Meta-analysis', Addiction 93:515-32.
52. Mason, B. J., Kocsis, J. H., Melia, D., Khuri, E. T., Sweeney, J., Wells, A., Borg, L., Millman, R. B. and Kreek, M. J. (1998) 'Psychiatric Comorbidity in Methadone Maintained Patients', Journal of Addictive Diseases 17: 75-89.
53. Mast, E. E., Alter, M. J. and Margolis, H. S. (1999) 'Strategies to Prevent and Control Hepatitis B and C Virus Infections: A Global Perspective', Vaccine 17: 1,730-3.
54. Menezes, P. R., Johnson, S., Thornicroft, G., Marshall, J., Prosser, D., Bebbington, P. and Kuipers, E. (1996) 'Drug and Alcohol Problems among Individuals with Severe Mental Illness in South London', British Journal of Psychiatry 168: 612-19.
55. Moggi, F., Hirsbrunner, H. P., Brodbeck, J. and Bachmann, K. M. (1999a) 'One-year Outcome of an Integrative Inpatient Treatment for Dual Diagnosis Patients', Addictive Behaviors 24: 589-92.
56. Moggi, F., Ouimette, P. C., Finney, J. W. and Moos, R. H. (1999b) 'Effectiveness of Treatment for Substance Abuse and Dependence for Dual Diagnosis Patients: A Model of Treatment Factors Associated with One-year Outcomes', Journal of Studies on Alcohol 60:856-66.
57. Musselman, D. L. and Kell, M. J. (1995) 'Prevalence and Improvement in Psychopathology in Opioid Dependent Patients Participating in Methadone Maintenance', Journal of Addictive Diseases 14: 67-82.
58. Nigam, R., Schottenfield, R. and Kosten, T. R. (1992) 'Treatment of Dual Diagnosis Patients: A Relapse Prevention Group Approach', Journal of Substance Abuse Treatment 9:305-9.
59. Noonan, W. C. and Moyers, T. B. (1997) 'Motivational Interviewing', Journal of Substance Misuse 2: 8-16.
60. Nunes, E. V., Quitkin, F. M., Donovan, S. J., Delivannides, D., Ocepek-Welikson, K., Koenig, T., Brady, R., McGrath, P. J. and Woody, G. (1998) 'Imipramine Treatment of Opiate-dependent Patients with Depressive Disorders. A Placebo-controlled Trial', Archives of General Psychiatry 55: 153-60.
61. Oyefeso, A., Ghodse, H., Clancy, C. and Corkery, J. M. (1999) 'Suicide among Drug Addicts in the UK', British Journal of Psychiatry 175: 277-82.
62. Penk, W. E., Flannery, R. B. Jr, Irvin, E., Geller, J., Fisher, W. and Hanson, M. A. (2000) 'Characteristics of Substance-abusing Persons with Schizophrenia: The Paradox of the Dually Diagnosed', Journal of Addictive Diseases 19: 23-30.
63. Poole, R. and Brabbins, C. (1996) 'Drug Induced Psychosis', British Journal of Psychiatry 168:135-8.
64. Pristach, C. A. and Smith, C. M. (1999) 'Attitudes Towards Alcoholics Anonymous by Dually Diagnosed Psychiatric Inpatients', Journal of Addictive Diseases 18: 69-76.
65. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. and Goodwin, F. K. (1990) 'Comorbidity of Mental Disorders with Alcohol and Other Drug Abuse', Journal of the American Medical Association 264: 2,511-18.
66. Reich, J. H. and Vasile, R. G. (1993) 'Effect of Personality Disorders on the Treatment Outcome of Axis I Conditions: An Update', Journal of Nervous and Mental Disease 181:475-83.
67. Rounsaville, B. J., Weissman, M. M., Klever, H. and Wilber, C. (1982) 'Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts', Archives of General Psychiatry 39: 161-6.
68. Scott, H., Johnson, S., Menezes, P., Thornicroft, G., Marshall, J., Bindman, J., Bebbington, P. and Kuipers, E. (1998) 'Substance Misuse and Risk of Aggression and Offending among the Severely Mentally Ill', British Journal of Psychiatry 172: 345-50.
69. Seivewright, N. (2000a) 'Dual Diagnosis-Drug Misuse and Psychiatric Disorder', in Community Treatment of Drug Misuse: More than Methadone, Cambridge: Cambridge University Press.
70. Seivewright, N. (2000b) 'Achieving Detoxification and Abstinence-Naltrexone', in Community Treatment of Drug Misuse: More than Methadone, Cambridge: Cambridge University Press.
71. Seivewright, N. (2000c) 'Treatment of Non-opiate Misuse-Cocaine and Amphetamine', in Community Treatment of Drug Misuse: More than Methadone, Cambridge: Cambridge University Press.
72. Seivewright, N. (2000d) 'Achieving Detoxification and Abstinence-Quick Detoxifications from Heroin', in Community Treatment of Drug Misuse: More than Methadone, Cambridge:Cambridge University Press.
73. Seivewright, N. (2000e) 'More than Methadone? The Case for Other Substitute Drugs', in Community Treatment of Drug Misuse: More than Methadone, Cambridge: Cambridge University Press.
74. Seivewright, N. and Daly, C. (1997) 'Personality Disorder and Drug Use: A Review', Drug and Alcohol Review 16: 235-50.
75. Sloan, K. L. and Rowe, G. (1998) 'Substance Abuse and Psychiatric Illness: Treatment Experience', American Journal of Drug and Alcohol Abuse 24: 589-601.
76. Solowij, N. (1993) 'Ecstasy (3,4-Methylenedioxymethamphetamine)', Current Opinion in Psychiatry 6: 411-15.
77. Strang, J., Sheridan, J. and Barber, N. (1996) 'Prescribing Injectable and Oral Methadone to Opiate Addicts: Results from the 1995 National Postal Survey of Community Pharmacies in England and Wales', British Medical Journal 313: 270-2.
78. Strang, J., Bearn, J. and Gossop, M. (1999) 'Lofexidine for Opiate Detoxification: Review of Recent Randomised and Open Controlled Trials', American Journal on Addictions 8:337-48.
79. Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G. and Inderbitzin, L. B. (1996) 'Substance Use: A Powerful Predictor of Relapse in Schizophrenia', Schizophrenia Research 20: 145-51.
80. Swofford, C. D., Scheller-Gilkey, G., Miller, A. H., Woolmine, B. and Mance, R. (2000) 'Double Jeopardy: Schizophrenia and Substance Use', American Journal of Drug and Alcohol Abuse 26: 343-53.
81. Taylor, S. M., Galanter, M., Dermatis, H., Spivack, N. and Egelko, S. (1997) 'Dual Diagnosis Patients in the Modified Therapeutic Community: Does a Criminal History Hinder Adjustment to Treatment?', Journal of Addictive Diseases 16: 31-8.
82. Trull, T. J., Sher, K. J. and Minks-Brown, C. (2000) 'Borderline Personality Disorder and Substance Use Disorders: A Review and Integration', Clinical Psychology Review 20:235-53.
83. Verheul, R., van den Brink, W. and Hartgers, C. (1995) 'Prevalence of Personality Disorders among Alcoholics and Drug Addicts: An Overview', European Addiction Research 1:166-77.
84. Westreich, L., Galanter, M., Lifshutz, H., Metzger, E. J. and Silberstein, C. (1996) 'A Modified Therapeutic Community for the Dually Diagnosed: Greenhouse Program at Bellevue Hospital', Journal of Substance Abuse Treatment 13: 533-6.
85. Ziedonis, D. M. and Trudeau, K. (1997) 'Motivation to Quit Using Substances among Individuals with Schizophrenia: Implications for a Motivation-based Treatment Model', Schizophrenia Bulletin 23: 229-38.
86. Zimmet, S. V., Strous, R. D., Burgess, E. S., Kohnstamm, S. and Green, A. I. (2000) 'Effects of Clozapine on Substance Use in Patients with Schizophrenia and Schizoaffective Disorder: A Retrospective Survey', Journal of Clinical Psychopharmacology 20: 94-8.